185 related articles for article (PubMed ID: 35181483)
21. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG
JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Foley D; Sievert H; Mazzone P; De Potter T; Vireca E; Stein K; Bergmann MW;
Heart Rhythm; 2017 Sep; 14(9):1302-1308. PubMed ID: 28577840
[TBL] [Abstract][Full Text] [Related]
23. Utilization and procedural adverse outcomes associated with Watchman device implantation.
Khalil F; Arora S; Killu AM; Tripathi B; DeSimone CV; Egbe A; Noseworthy PA; Kapa S; Mulpuru S; Gersh B; Mohamad A; Friedman P; Holmes D; Deshmukh AJ
Europace; 2021 Feb; 23(2):247-253. PubMed ID: 32929501
[TBL] [Abstract][Full Text] [Related]
24. Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion.
Friedman DJ; Du C; Zimmerman S; Tan Z; Lin Z; Vemulapalli S; Kosinski AS; Piccini JP; Pereira L; Minges KE; Faridi KF; Masoudi FA; Curtis JP; Freeman JV
Circ Cardiovasc Interv; 2024 Jun; 17(6):e013466. PubMed ID: 38889251
[TBL] [Abstract][Full Text] [Related]
25. Sex-related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry.
Paitazoglou C; Eitel I; Stiermaier T; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Vireca E; Wohlmuth P; Lucas B; Bergmann MW;
Catheter Cardiovasc Interv; 2023 Aug; 102(2):283-292. PubMed ID: 37393575
[TBL] [Abstract][Full Text] [Related]
26. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
Simard T; Jung RG; Lehenbauer K; Piayda K; Pracoń R; Jackson GG; Flores-Umanzor E; Faroux L; Korsholm K; Chun JKR; Chen S; Maarse M; Montrella K; Chaker Z; Spoon JN; Pastormerlo LE; Meincke F; Sawant AC; Moldovan CM; Qintar M; Aktas MK; Branca L; Radinovic A; Ram P; El-Zein RS; Flautt T; Ding WY; Sayegh B; Benito-González T; Lee OH; Badejoko SO; Paitazoglou C; Karim N; Zaghloul AM; Agrawal H; Kaplan RM; Alli O; Ahmed A; Suradi HS; Knight BP; Alla VM; Panaich SS; Wong T; Bergmann MW; Chothia R; Kim JS; Pérez de Prado A; Bazaz R; Gupta D; Valderrabano M; Sanchez CE; El Chami MF; Mazzone P; Adamo M; Ling F; Wang DD; O'Neill W; Wojakowski W; Pershad A; Berti S; Spoon D; Kawsara A; Jabbour G; Boersma LVA; Schmidt B; Nielsen-Kudsk JE; Rodés-Cabau J; Freixa X; Ellis CR; Fauchier L; Demkow M; Sievert H; Main ML; Hibbert B; Holmes DR; Alkhouli M
J Am Coll Cardiol; 2021 Jul; 78(4):297-313. PubMed ID: 34294267
[TBL] [Abstract][Full Text] [Related]
27. Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study.
Bergmann MW; Ince H; Kische S; Schmitz T; Meincke F; Schmidt B; Foley D; Betts TR; Grygier M; Protopopov AV; Stein KM; Boersma LVA
EuroIntervention; 2018 Apr; 13(17):2003-2011. PubMed ID: 29313819
[TBL] [Abstract][Full Text] [Related]
28. Caged-in: Successful percutaneous closure of left atrial appendage with Watchman-FLX in the presence of proximal thrombus.
Briosa E Gala A; Pope MTB; Newton JD; Dawkins S; Betts TR
J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1655-1657. PubMed ID: 33938078
[TBL] [Abstract][Full Text] [Related]
29. Intracardiac echocardiography- versus transesophageal echocardiography-guided left atrial appendage occlusion with Watchman FLX.
Gianni C; Horton RP; Della Rocca DG; Mohanty S; Al-Ahmad A; Bassiouny MA; Burkhardt JD; Gallinghouse GJ; Hranitzky PM; Sanchez JE; Natale A
J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2781-2784. PubMed ID: 34411376
[TBL] [Abstract][Full Text] [Related]
30. Impact of operatoŕs experience on
Cruz-González I; Torres Saura F; Trejo-Velasco B; Antonio Fernández Díaz J; Fajardo Molina R; Del Valle-Fernández R; Moreno Terribas G; Martí Sánchez D; López-Mínguez JR; Gomez-Blazquez I; Sanmartin Pena JC; Botas J; Martin Lorenzo P; Palazuelos J; Albarrán Rincon R; Mohandes M; Rodriguez Entem FJ; Martí G; Valero E; Gutiérrez H; Amat-Santos IJ; Nombela-Franco L; Salinas P; Teruel L; Gomez-Hospital JA; Arzamendi D; Torres Sanabria M; Calle Pérez G; Cañadas Pruaño D; Pérez de Prado A; Benito González T; Arroyo-Úcar E; Estévez-Loureiro R; Caneiro-Queija B; Ibañez Criado JL; Ruiz-Nodar JM
Int J Cardiol Heart Vasc; 2022 Feb; 38():100941. PubMed ID: 35024431
[TBL] [Abstract][Full Text] [Related]
31. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
[TBL] [Abstract][Full Text] [Related]
32. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes and periprocedural safety and efficacy of percutaneous left atrial appendage closure in a United Kingdom tertiary center: An 11-year experience.
Briosa E Gala A; Pope MTB; Monteiro C; Leo M; Dawkins S; Newton JD; Betts TR
Heart Rhythm; 2021 Oct; 18(10):1724-1732. PubMed ID: 34126270
[TBL] [Abstract][Full Text] [Related]
34. Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings.
Sakriss C; Roehl P; Schwenzky A; Hoyme M; Ebelt H
Open Heart; 2023 Mar; 10(1):. PubMed ID: 36918230
[TBL] [Abstract][Full Text] [Related]
35. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.
Boersma LV; Schmidt B; Betts TR; Sievert H; Tamburino C; Teiger E; Pokushalov E; Kische S; Schmitz T; Stein KM; Bergmann MW;
Eur Heart J; 2016 Aug; 37(31):2465-74. PubMed ID: 26822918
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry.
Mazzone P; D'Angelo G; Regazzoli D; Molon G; Senatore G; Saccà S; Canali G; Amellone C; Turri R; Bella PD
J Interv Card Electrophysiol; 2018 Jun; 52(1):47-52. PubMed ID: 29525913
[TBL] [Abstract][Full Text] [Related]
37. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
[TBL] [Abstract][Full Text] [Related]
38. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E
Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598
[TBL] [Abstract][Full Text] [Related]
39. Watchman FLX Implantation for Challenging Left Atrial Appendage Anatomy: Case-Based Discussion.
Joury A; Englert JAR; Bernard M; Jenkins JS; Dinshaw H; Gilliland Y; Qamruddin S
Curr Probl Cardiol; 2022 Sep; 47(9):101266. PubMed ID: 35644503
[TBL] [Abstract][Full Text] [Related]
40. Watchman device migration and embolization: A report from the NCDR LAAO Registry.
Friedman DJ; Freeman JV; Zimmerman S; Tan Z; Pereira L; Faridi KF; Curtis JP
J Cardiovasc Electrophysiol; 2023 May; 34(5):1192-1195. PubMed ID: 37078339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
